Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.85
-0.03 (-0.44%)
At close: Mar 6, 2026, 4:00 PM EST
6.80
-0.05 (-0.73%)
After-hours: Mar 6, 2026, 4:18 PM EST
Cartesian Therapeutics Employees
Cartesian Therapeutics had 66 employees as of December 31, 2024. The number of employees increased by 28 or 73.68% compared to the previous year.
Employees
66
Change (1Y)
28
Growth (1Y)
73.68%
Revenue / Employee
$16,530
Profits / Employee
-$726,955
Market Cap
178.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66 | 28 | 73.68% |
| Dec 31, 2023 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 166 |
| Nkarta | 105 |
| Vaxart | 105 |
| Tenaya Therapeutics | 97 |
| Tonix Pharmaceuticals Holding | 81 |
| SAB Biotherapeutics | 63 |
| Sagimet Biosciences | 14 |
| Tiziana Life Sciences | 9 |
RNAC News
- 4 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors - GlobeNewsWire
- 3 months ago - Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis - Seeking Alpha
- 5 months ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 6 months ago - Cartesian Therapeutics, Inc. (RNAC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 6 months ago - Cartesian Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 10 months ago - Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis - GlobeNewsWire